[EN] S-ANTIGEN TRANSPORT INHIBITING OLIGONUCLEOTIDE POLYMERS AND METHODS<br/>[FR] POLYMÈRES OLIGONUCLÉOTIDIQUES INHIBANT LE TRANSPORT DE L'ANTIGÈNE S ET MÉTHODES
申请人:ALIGOS THERAPEUTICS INC
公开号:WO2021119325A1
公开(公告)日:2021-06-17
Various embodiments provide STOPS™ polymers that are S-antigen transport inhibiting oligonucleotide polymers, processes for making them and methods of using them to treat diseases and conditions. In some embodiments the STOPS™ modified oligonucleotides include an at least partially phosphorothioated sequence of alternating A and C units having modifications as described herein. The sequence independent antiviral activity against hepatitis B of embodiments of STOPS™ modified oligonucleotides, as determined by HBsAg Secretion Assay, is an EC50 that is less than 100 nM.
WHEELER, WILLIAM J.;MABRY, THOMAS E.;JONES, C. DAVID, J. LABELL. COMPOUNDS AND RADIOPHARM. , 29,(1991) N, C. 583-589
作者:WHEELER, WILLIAM J.、MABRY, THOMAS E.、JONES, C. DAVID
DOI:——
日期:——
Gemcitabine, Pyrrologemcitabine, and 2′-Fluoro-2′-Deoxycytidines: Synthesis, Physical Properties, and Impact of Sugar Fluorination on Silver Ion Mediated Base Pairing
作者:Xiurong Guo、Peter Leonard、Sachin A. Ingale、Frank Seela
DOI:10.1002/chem.201703427
日期:2017.12.14
duplexes with fluorinated sugar residues than for those with an unchanged 2′‐deoxyribose moiety. Similar observations were made for “dC‐dT” pairs and to a minor extent for “dC‐dA” pairs. The increase in silver ion mediated base‐pair stability was reversed by annulation of a pyrrole ring to the cytosine moiety, as shown for 2′‐fluorinated phPyrGem in comparison with phenylpyrrolo‐dC (phPyrdC). This